4//SEC Filing
Dorval Allison 4
Accession 0001437749-24-020566
CIK 0001401667other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 7:18 PM ET
Size
5.1 KB
Accession
0001437749-24-020566
Insider Transaction Report
Form 4
Dorval Allison
Director
Transactions
- Sale
Common Stock
2024-06-13$3.37/sh−11,000$37,096→ 33,000 total
Footnotes (2)
- [F1]Adoption date of referenced 10b5-1(c) sell to cover program is: 03-06-2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001625110
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 7:18 PM ET
- Size
- 5.1 KB